Article
A novel pharmacogenetic testing panel for <i>CYP2C19</i> genetic polymorphisms
2026-02-17
Abstract excerpt
Specific drug metabolism rates are defined by the constituency of the cytochrome P450 (CYP) genome, including polymorphic changes in any of 200+ CYP genes. An example is CYP2C19, where associations of gene polymorphisms with variability in certain drug metabolism rates have been linked to inter-individual and inter-ethnic differences in therapeutic outcomes. While pharmacogenomic screening for these variants prio...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f7b36676-cd7d-5a8d-b58d-462291fb9d63
- DOI
- 10.64898/2026.02.14.705357
